Resistance to chemotherapy in cancer: a complex and integrated cellular response.
作者： Howard R. Mellor , Richard Callaghan
DOI: 10.1159/000115967
关键词:
摘要: … to successful chemotherapy. As outlined in this review, the resistant phenotype is an adaptive response of cancer cells and comprises multiple pathways. Moreover, cancer cells often …
karger.com
researchgate.net 
sci-hub.se 参考文章(281)
Giuseppe Giaccone, Franco Zunino, Giovanni Capranico, Hans Beck, Adi F. Gazdar, Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Research. ,vol. 52, pp. 1666- 1674 ,(1992)
Stephen B. Baylln, James G. Herman, Jeremy R. Graff, Paula M. Vertino, Jean-Pierre Issa, ALTERATIONS IN DNA METHYLATION : A FUNDAMENTAL ASPECT OF NEOPLASIA Advances in Cancer Research. ,vol. 72, pp. 141- 196 ,(1998) , 10.1016/S0065-230X(08)60702-2
Demetrius M. Kokkinakis, Jorge Albores-Saavedra, Mansoor M. Ahmed, Mushdaq M. Fruitwala, Ruby Delgado, Mohammed Mohiuddin, Role of O6-Methylguanine-DNA Methyltransferase in the Resistance of Pancreatic Tumors to DNA Alkylating Agents Cancer Research. ,vol. 57, pp. 5360- 5368 ,(1997)
Josef Jiricny, Mirco Menigatti, Petr Cejka, Giancarlo Marra, Massimiliano di Pietro, Lovorka Stojic, Maria Sofia Cattaruzza, Mismatch Repair-Dependent Transcriptome Changes In Human Cells Treated with the Methylating Agent N-Methyl-N′-Nitro-N-Nitrosoguanidine Cancer Research. ,vol. 63, pp. 8158- 8166 ,(2003) , 10.5167/UZH-31248
M Massobrio, D Katsaros, GL Scheffer, Albert Suurmeijer, M Kool, Hjg Arts, S Danese, R Arisio, de Elisabeth G. E. Vries, RJ Scheper, F Genta, Phb Willemse, van der Ate Zee, Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clinical Cancer Research. ,vol. 5, pp. 2798- 2805 ,(1999)
P W Melera, J P Davide, H Oen, Antifolate-resistant Chinese hamster cells. Molecular basis for the biochemical and structural heterogeneity among dihydrofolate reductases produced by drug-sensitive and drug-resistant cell lines. Journal of Biological Chemistry. ,vol. 263, pp. 1978- 1990 ,(1988) , 10.1016/S0021-9258(19)77974-5
J.J. McGuire, P. Hsieh, J.K. Coward, J.R. Bertino, Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products. Journal of Biological Chemistry. ,vol. 255, pp. 5776- 5788 ,(1980) , 10.1016/S0021-9258(19)70697-8
Jeffrey G Supko, Rocio Garcia-Carbonero, Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins Clinical Cancer Research. ,vol. 8, pp. 641- 661 ,(2002)
L. L. Siu, R. Pflueger, R. J. Khurana, D. Banerjee, I. F. Tannock, Xia Pan, M. J. Moore, The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma. Clinical Cancer Research. ,vol. 4, pp. 559- 565 ,(1998)
Wendell K, Jordan Ma, Wilson L, Copp H, Gardiner S, Derry Wb, Mitotic Block Induced in HeLa Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death Cancer Research. ,vol. 56, pp. 816- 825 ,(1996)